# Title
Mutations O
in O
the O
human B-Species
UDP-N-acetylglucosamine O
2-epimerase O
gene O
define O
the O
disease O
sialuria B-Disease
and O
the O
allosteric O
site O
of O
the O
enzyme. O

# Abstract
Sialuria B-Disease
is O
a O
rare O
inborn B-Disease
error I-Disease
of I-Disease
metabolism I-Disease
characterized O
by O
cytoplasmic O
accumulation O
and O
increased O
urinary O
excretion O
of O
free O
N-acetylneuraminic B-Chemical
acid I-Chemical
(NeuAc, B-Chemical
sialic B-Chemical
acid). I-Chemical
Overproduction O
of O
NeuAc B-Chemical
is O
believed O
to O
result O
from O
loss O
of O
feedback O
inhibition O
of O
uridinediphosphate-N-acetylglucosamine O
2-epimerase O
(UDP-GlcNAc O
2-epimerase) O
by O
cytidine B-Chemical
monophosphate-N-acetylneuraminic I-Chemical
acid I-Chemical
(CMP-Neu5Ac). O
We O
report O
the O
cloning O
and O
characterization O
of O
human B-Species
UDP-GlcNAc O
2-epimerase O
cDNA, O
with O
mutation O
analysis O
of O
three O
patients B-Species
with O
sialuria. B-Disease
Their O
heterozygote O
mutations, O
R266W, B-ProteinMutation
R266Q, B-ProteinMutation
and O
R263L, B-ProteinMutation
indicate O
that O
the O
allosteric O
site O
of O
the O
epimerase O
resides O
in O
the O
region O
of O
codons O
263-266. O
The O
heterozygous O
nature O
of O
the O
mutant O
allele O
in O
all O
three O
patients B-Species
reveals O
a O
dominant O
mechanism O
of O
inheritance O
for O
sialuria. B-Disease